This is a genetic condition that causes tumors to grow in several glands in the body. These glands include the parathyroid glands (which control calcium levels), the pituitary gland (which controls hormones), and the pancreas. People with this condition often develop problems like high calcium levels, high prolactin levels, high cortisol levels, and tumors in the pancreas. It's inherited, meaning you get it from your parents.
Every report comes from a Lived member, sent anonymously.
Have you had Parathyroidectomy for Multiple Endocrine Neoplasia Type 1?
Multiple endocrine neoplasia type 1 (MEN1) is a rare inherited condition that causes tumors to grow in several of the body's hormone-making (endocrine) glands. The glands most often involved are the parathyroid glands in the neck, the pituitary gland at the base of the brain, and hormone-producing cells in the pancreas and the first part of the small intestine (the duodenum). MEN1 was previously called Wermer syndrome. Most MEN1 tumors are not cancer, but they still matter because many of them make too much of a hormone. Overactive parathyroid glands, the most common problem, raise blood calcium and can lead to kidney stones, bone thinning, tiredness and constipation. Pituitary tumors can cause hormone changes such as irregular periods, breast milk discharge or reduced sex drive. Tumors in the pancreas or duodenum can cause stomach ulcers and diarrhea, or episodes of low blood sugar, and some of them can become cancerous and spread. MEN1 affects about 1 in 30,000 people, men and women equally. First symptoms often appear in the late teens or 20s, usually from the parathyroid glands, although many people are not diagnosed until their 40s. It is different from MEN type 2, which involves another gene and a different set of tumors.
MEN1 is caused by a change (variant) in the MEN1 gene. This gene normally makes a protein called menin that helps keep cells from growing and dividing too quickly. People with MEN1 are born with one faulty copy of the gene. Over a lifetime, the second copy is damaged in a few cells, and those cells can then grow into tumors. This is why tumors appear gradually and why almost everyone who carries the variant eventually develops some of them. The condition is inherited in an autosomal dominant way: a parent with MEN1 has a 50% chance of passing it to each child, regardless of sex. About 1 in 10 people with MEN1 have a new variant that was not inherited, so a lack of family history does not rule it out. Nothing a person did caused the condition. Which tumors develop, and when, varies widely, even among relatives who share the same variant. Smoking raises the risk of carcinoid tumors, a type of slow-growing neuroendocrine tumor that in MEN1 can arise in the thymus (a gland in the chest) or the lungs. Thymic tumors are uncommon but can be aggressive and occur mostly in men.
MEN1 can be diagnosed in three ways: finding two or more of the typical tumors (parathyroid, pituitary, or pancreas and duodenum); finding one typical tumor in someone whose parent, sibling or child has MEN1; or finding a disease-causing MEN1 variant on genetic testing, even before any symptoms. Blood tests show whether glands are overactive. A high calcium level together with a high or not-suppressed parathyroid hormone (PTH) level points to overactive parathyroid glands. Other blood tests measure hormones such as prolactin, gastrin, insulin and blood sugar. MRI, CT, ultrasound and specialized scans that detect hormone receptors on tumors look for tumors that make no hormones and cause no symptoms. Genetic testing is usually done on a blood or saliva sample after genetic counseling. It is recommended for people with suspected MEN1, for example overactive parathyroid glands before age 30 or in more than one gland, and for the parents, siblings and children of anyone with a known MEN1 variant. Children in an affected family can be tested from around age 5, since tumors occasionally begin in childhood. A relative who tests negative for the family's variant does not have MEN1 and needs no MEN1 screening. In a meaningful minority of people who look clinically like MEN1, no variant is found, so a negative test in that situation does not settle the question.
There is no cure for the inherited gene change, but each tumor can be treated, and regular screening aims to find problems before they cause harm. Small tumors that make no hormones and are not growing are often watched with blood tests and imaging rather than removed. Because people with MEN1 often have several tumors at once, care is best coordinated by an endocrinologist and surgeons experienced with the condition. For overactive parathyroid glands, surgery is the main treatment. Since all four glands are usually affected, surgeons typically remove three and a half glands, along with the thymus. The operation can bring calcium back to normal for years, but overactivity often returns, and too little parathyroid tissue can leave calcium too low, requiring calcium and vitamin D long term. When surgery is not possible or has not worked, cinacalcet, a pill that signals the parathyroid glands to make less hormone, can lower calcium. Pituitary tumors are treated much as they are in people without MEN1. A prolactin-producing tumor is usually treated first with a dopamine agonist pill such as cabergoline, which lowers prolactin and often shrinks the tumor. Most other pituitary tumors that need treatment are removed through the nose, and radiation is used less often. For gastrinomas, proton pump inhibitors such as omeprazole sharply reduce stomach acid and control ulcers and diarrhea. Insulinomas are usually removed surgically, which typically stops the low blood sugar episodes. Pancreatic tumors that are larger or growing are often removed to lower the risk of spread. Surgery can control symptoms and is linked to good long-term survival, but new tumors commonly develop in the remaining pancreas, and extensive pancreas surgery can cause diabetes or problems digesting food. Tumors that have spread may be treated with medicines that slow tumor growth, targeted radiation treatments or chemotherapy.
MEN1 is a lifelong condition in which new tumors can appear over many years, so most people move through cycles of monitoring and, at times, treatment. Most people with MEN1 lead long and productive lives, although life expectancy is somewhat shorter on average than in the general population. Pancreatic tumors that become cancerous and spread are the most common MEN1-related cause of death, which is why the pancreas is watched closely. Surveillance usually means yearly blood tests for calcium, parathyroid hormone, prolactin, blood sugar and other tumor markers, plus imaging of the brain, abdomen and chest every few years, adjusted to age and findings. Women with MEN1 have a moderately higher risk of breast cancer, and earlier screening, from around age 40, may be recommended. Pregnancy with untreated overactive parathyroid glands raises the risk of preeclampsia, so planning a pregnancy with the care team is worthwhile. The condition also affects families. A diagnosis often leads to testing of relatives, decisions about children's testing and questions about future pregnancies. Genetic counselors can help with these decisions and with connecting families to support groups. Ongoing appointments, repeated scans and the uncertainty of watching for new tumors can be tiring, and many people find it helpful to have one clinician coordinating their care.
Ask about MEN1 evaluation if a parent, brother, sister or child has MEN1, or if you have overactive parathyroid glands at a young age, in more than one gland or along with another hormone tumor. If you have MEN1, keep up with scheduled screening even when you feel well. Contact your care team promptly about new kidney stones, ongoing heartburn or stomach pain, persistent diarrhea, new vision changes or persistent headaches, or episodes of shakiness, sweating or confusion that improve after eating, which can signal low blood sugar from an insulinoma. If someone with suspected low blood sugar passes out, has a seizure or cannot safely eat or drink, call 911.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Multiple Endocrine Neoplasia Type 1 is like, what's helped you, or ask the community a question.